Free Trial

Duke Capital (DUKE) Competitors

Duke Capital logo
GBX 28.75 +0.25 (+0.88%)
(As of 11/21/2024 ET)

DUKE vs. JPGI, CGI, FSFL, ATR, GHE, PAC, BHGG, PCGH, NAIT, and POLN

Should you be buying Duke Capital stock or one of its competitors? The main competitors of Duke Capital include Jpmorgan Global Growth & Income (JPGI), Canadian General Investments (CGI), Foresight Solar (FSFL), Schroder Asian Total Return Inv. (ATR), Gresham House (GHE), Pacific Assets (PAC), BH Global (BHGG), Polar Capital Glb Healthcare (PCGH), North American Income Trust (NAIT), and Pollen Street Group (POLN). These companies are all part of the "asset management" industry.

Duke Capital vs.

Jpmorgan Global Growth & Income (LON:JPGI) and Duke Capital (LON:DUKE) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, community ranking, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

Duke Capital has a net margin of 45.72% compared to Jpmorgan Global Growth & Income's net margin of 0.00%. Duke Capital's return on equity of 7.05% beat Jpmorgan Global Growth & Income's return on equity.

Company Net Margins Return on Equity Return on Assets
Jpmorgan Global Growth & IncomeN/A N/A N/A
Duke Capital 45.72%7.05%5.61%

Duke Capital has a consensus price target of GBX 55, indicating a potential upside of 91.30%. Given Duke Capital's stronger consensus rating and higher probable upside, analysts plainly believe Duke Capital is more favorable than Jpmorgan Global Growth & Income.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jpmorgan Global Growth & Income
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Duke Capital
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

36.1% of Duke Capital shares are held by institutional investors. 6.3% of Duke Capital shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Duke Capital has lower revenue, but higher earnings than Jpmorgan Global Growth & Income. Jpmorgan Global Growth & Income is trading at a lower price-to-earnings ratio than Duke Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jpmorgan Global Growth & Income£93.27M0.00N/A£67.80N/A
Duke Capital£25.39M4.72£11.61M£0.03958.33

Duke Capital received 6 more outperform votes than Jpmorgan Global Growth & Income when rated by MarketBeat users. Likewise, 73.97% of users gave Duke Capital an outperform vote while only 68.00% of users gave Jpmorgan Global Growth & Income an outperform vote.

CompanyUnderperformOutperform
Jpmorgan Global Growth & IncomeOutperform Votes
102
68.00%
Underperform Votes
48
32.00%
Duke CapitalOutperform Votes
108
73.97%
Underperform Votes
38
26.03%

In the previous week, Duke Capital had 3 more articles in the media than Jpmorgan Global Growth & Income. MarketBeat recorded 3 mentions for Duke Capital and 0 mentions for Jpmorgan Global Growth & Income. Duke Capital's average media sentiment score of 0.45 beat Jpmorgan Global Growth & Income's score of 0.00 indicating that Duke Capital is being referred to more favorably in the news media.

Company Overall Sentiment
Jpmorgan Global Growth & Income Neutral
Duke Capital Neutral

Jpmorgan Global Growth & Income pays an annual dividend of GBX 0.13 per share. Duke Capital pays an annual dividend of GBX 3 per share and has a dividend yield of 10.4%. Jpmorgan Global Growth & Income pays out 0.2% of its earnings in the form of a dividend. Duke Capital pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Duke Capital beats Jpmorgan Global Growth & Income on 14 of the 17 factors compared between the two stocks.

Get Duke Capital News Delivered to You Automatically

Sign up to receive the latest news and ratings for DUKE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DUKE vs. The Competition

MetricDuke CapitalAsset Management IndustryFinancial SectorLON Exchange
Market Cap£119.81M£866.73M£3.51B£1.48B
Dividend Yield8.42%13.18%4.53%11.31%
P/E Ratio958.33771.14428.131,555.25
Price / Sales4.7213,608.002,058.28230,707.99
Price / Cash5.4987.0150.3234.77
Price / Book0.721.761.492.90
Net Income£11.61M£62.32M£348.60M£136.54M
7 Day Performance-4.17%-0.21%0.20%-0.55%
1 Month Performance-13.40%-0.48%0.75%3.51%
1 Year Performance-8.00%10.61%15.89%102.98%

Duke Capital Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DUKE
Duke Capital
2.18 of 5 stars
GBX 28.75
+0.9%
GBX 55
+91.3%
-8.7%£119.81M£25.39M958.33N/A
JPGI
Jpmorgan Global Growth & Income
N/AN/AN/A+0.0%£472.52M£93.27M5.01N/AHigh Trading Volume
CGI
Canadian General Investments
N/AN/AN/A+11.8%£468.33M£201.31M514.93N/A
FSFL
Foresight Solar
N/AGBX 80.80
+0.7%
N/A-15.8%£459.05M£28.20M-3,999.45N/ADividend Announcement
ATR
Schroder Asian Total Return Inv.
N/AGBX 479
+1.5%
N/A+13.7%£458.60M£41.66M1,368.5713,500News Coverage
GHE
Gresham House
N/AGBX 1,100
flat
N/AN/A£451.55M£86.03M3,055.56216
PAC
Pacific Assets
N/AGBX 373
flat
N/A+0.9%£451.18M£5.84M-7,440.061,740
BHGG
BH Global
N/AGBX 1,925
flat
N/AN/A£444.68M£837,000.005.12N/A
PCGH
Polar Capital Glb Healthcare
N/AGBX 363
flat
N/A+20.6%£440.21MN/A4,033.33N/ADividend Increase
NAIT
North American Income Trust
N/AGBX 337
+0.9%
N/A+25.1%£436.89M£-2,930,000.00-4,771.43N/A
POLN
Pollen Street Group
2.7982 of 5 stars
N/AGBX 905
+∞
+18.2%£436.48M£108.82M1,000.0084

Related Companies and Tools


This page (LON:DUKE) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners